|
1
|
Vollenhoven B and Hunt S: Ovarian ageing
and the impact on female fertility. F1000 Res 7: F1000 Faculty
Rev-1835, 2018.
|
|
2
|
Lew R: Natural history of ovarian function
including assessment of ovarian reserve and premature ovarian
failure. Best Pract Res Clin Obstet Gynaecol. 55:2–13.
2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sfakianoudis K, Simopoulou M, Grigoriadis
S, Pantou A, Tsioulou P, Maziotis E, Rapani A, Giannelou P, Nitsos
N, Kokkali G, et al: Reactivating ovarian function through
autologous platelet-rich plasma intraovarian infusion: Pilot data
on premature ovarian insufficiency, perimenopausal, menopausal, and
poor responder women. J Clin Med. 9(1809)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ferraretti AP, La Marca A, Fauser BC,
Tarlatzis B, Nargund G and Gianaroli L: ESHRE working group on poor
ovarian response definition. ESHRE consensus on the definition of
‘poor response’ to ovarian stimulation for in vitro fertilization:
The Bologna criteria. Hum Reprod. 26:1616–1624. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Humaidan P, Alviggi C, Fischer R and
Esteves SC: The novel POSEIDON stratification of ‘Low prognosis
patients in Assisted Reproductive Technology’ and its proposed
marker of successful outcome. F1000Res. 5(2911)2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Winship AL, Stringer JM, Liew SH and Hutt
KJ: The importance of DNA repair for maintaining oocyte quality in
response to anti-cancer treatments, environmental toxins and
maternal ageing. Hum Reprod Update. 24:119–134. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Roman R, Mussarat N and Detti L: Ovarian
stimulation in poor responders: Have We Made Progress? Curr Pharm
Biotechnol. 18:614–618. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Dimitriu M, Stoian AP, Rosu G, Dan A,
Caimacan A, Zygouropoulos N, Pacu I, Socea B, Ionescu C, Gheorghiu
DC, et al: Postpartum depression-a serious, dangerous, disabling,
extremely frequent condition that is almost completely ignored in
Romania. Mediterr J Clin Psychol. 8:1–24. 2020.
|
|
9
|
Regan SLP, Knight PG, Yovich JL, Arfuso F
and Dharmarajan A: Growth hormone during in vitro fertilization in
older women modulates the density of receptors in granulosa cells,
with improved pregnancy outcomes. Fertil Steril. 110:1298–1310.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mihalas BP, Redgrove KA, McLaughlin EA and
Nixon B: Molecular mechanisms responsible for increased
vulnerability of the ageing oocyte to oxidative damage. Oxid Med
Cell Longev. 2017(4015874)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Foster TE, Puskas BL, Mandelbaum BR,
Gerhardt MB and Rodeo SA: Platelet-rich plasma: From basic science
to clinical applications. Am J Sports Med. 37:2259–2272.
2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Schmitz JP and Hollinger JO: The biology
of platelet-rich plasma. J Oral Maxillofac Surg. 59:1119–1121.
2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hosseini L, Shirazi A, Naderi MM,
Shams-Esfandabadi N, Borjian Boroujeni S, Sarvari A, Sadeghnia S,
Behzadi B and Akhondi MM: Platelet-rich plasma promotes the
development of isolated human primordial and primary follicles to
the preantral stage. Reprod Biomed Online. 35:343–350.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Peterson JE, Zurakowski D, Italiano JE Jr,
Michel LV, Fox L, Klement GL and Folkman J: Normal ranges of
angiogenesis regulatory proteins in human platelets. Am J Hematol.
85:487–493. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Dawood AS and Salem HA: Current clinical
applications of platelet-rich plasma in various gynecological
disorders: An appraisal of theory and practice. Clin Exp Reprod
Med. 45:67–74. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Marques LF, Stessuk T, Camargo IC, Sabeh
Junior N, dos Santos L and Ribeiro-Paes JT: Platelet-rich plasma
(PRP): Methodological aspects and clinical applications. Platelets.
26:101–113. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tesarik J, Junca AM, Hazout A, Aubriot FX,
Nathan C, Cohen-Bacrie P and Dumont-Hassan M: Embryos with high
implantation potential after intracytoplasmic sperm injection can
be recognized by a simple, non-invasive examination of pronuclear
morphology. Hum Reprod. 15:1396–1399. 2000.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yu EJ, Ahn H, Lee JM, Jee BC and Kim SH:
Fertilization and embryo quality of mature oocytes with specific
morphological abnormalities. Clin Exp Reprod Med. 42:156–162.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Rienzi L, Ubaldi FM, Iacobelli M, Minasi
MG, Romano S, Ferrero S, Sapienza F, Baroni E, Litwicka K and Greco
E: Significance of metaphase II human oocyte morphology on ICSI
outcome. Fertil Steril. 90:1692–1700. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cakiroglu Y, Saltik A, Yuceturk A,
Karaosmanoglu O, Kopuk SY, Scott RT Jr, Tiras B and Seli E: Effects
of intraovarian injection of autologous platelet rich plasma on
ovarian reserve and IVF outcome parameters in women with primary
ovarian insufficiency. Aging (Albany NY). 12:10211–10222.
2020.PubMed/NCBI View Article : Google Scholar
|
